The Antibiotic Resistance Threat to Humanity | Ravina Kullar, PharmD MPH, FIDSA

10/28/20 • 25 min

1 Listener

Antimicrobial resistance is the ability of a pathogenic microbe to develop a resistance to the effects of an antimicrobial medication. The term antibiotic resistance is a subset of AMR, as it applies to bacteria that become resistant to antibiotics. Dr. Ravina Kullar is an Infectious Diseases global expert and researcher, who has spent almost 15 years researching in the infectious diseases space. She is actively leading strategies worldwide to educate the public about various infectious diseases topics. She has been invited to provide 3 TED talks, sharing her own personal patient stories and providing action items that everyone can implement to be a part of the solution of infectious diseases outbreaks. She has published over 40 research papers, and has been an invited speaker worldwide, educating both clinicians and the public. During the COVID-19 pandemic, Dr. Kullar has served as a public health advocate and leader, educating the public via various media outlets. She founded duXsana (https://duxsana.com/), where she, serving as the infectious diseases expert, and her team of construction experts and interior designers have guided businesses in reopening safely, keeping infection prevention at the forefront. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Previous Episode

The 3,000 Year Old Miracle Drug | GameChangers

The LoDoCo2 Trial suggested that colchicine may improve outcomes in patients with cardiovascular disease. Can a 3,000 year old drug still be a miracle? Additional Resources/References: Nidorf SM, Fiolet ATL, Mosterd A, et al; LoDoCo2 Trial Investigators. Colchicine in Patients with Chronic Coronary Disease. N Engl J Med. 2020 Aug 31. doi: 10.1056/NEJMoa2021372. Epub ahead of print. PMID: 32865380. This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today! See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Next Episode

Educational Marketing during Flu Season | Pharmacy Marketing Simplified

New flexibilities in delivering flu vaccinations could be a ‘game-changer’, but without them, pharmacies may struggle to run a flu vaccination program at all this winter. Pharmacies are preparing for what is expected to be a surge in flu vaccinations this year as Americans are putting a greater focus on staying healthy amid the coronavirus pandemic. Pharmacies are preparing for what is expected to be a surge in flu vaccinations this year as Americans are putting a greater focus on staying healthy amid the coronavirus pandemic. In anticipation of that double whammy of flu and covid-19, the disease caused by the novel coronavirus, flu vaccine manufacturers have boosted production by about 15 percent, to record levels, with nearly 200 million doses for the United States. During the 2019-2020 flu season, more than the 175 million doses were churned out, industry officials said. Contact the Pharmacy Marketing experts about Educational Marketing during the Flu season: PharmacyMarketing.com Sponsored by: UltiGuard Safe Pack is the only pen needle product that comes with an all-in-one sharps container. Learn more about why UltiGuard Safe Pack is the best choice for your patients and your pharmacy. Learn more UltiGuard Safe Pack https://www.ulticare.com/ultiguard-safe-pack/podcast See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices